Greg oversees all aspects of ATNI and is a member of ATNI's board (ex officio). Over the past two decades, Greg has established private-public partnerships that improve health and nutrition in emerging markets. Most recently, he served on the Global Executive Team of Drugs for Neglected Diseases initiative (DNDi), as Director of Business Development and Partnerships – engaging over two dozen pharmaceutical companies. Prior to this, he led strategy and business development at ThinkWell, a global health organization. From 2011 until 2019, Greg held several leadership roles at the Global Alliance for Improved Nutrition (GAIN), including Director of Policy & Financing and Director of Food Fortification. During this time, he oversaw a portfolio of micronutrient projects that reached approximately one billion people with nutritious foods and led the establishment of a multimillion-dollar impact investment facility (The N3F). Since joining ATNI as ED in 2022 he has led the development of a new five-year strategy and new initiatives in policy and investor engagement. Greg holds an MSc (Distinction) from the University of Bath and has previously served on the Boards of the Iodine Global Network and the Food Fortification Initiative.